510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K113020Substantially Equivalent

Immulisa Enhanced (Tm) Cardiolipin Iga, Igg, Igm and Iga/igg/igm Antibody (Aca) Elisas

Immco Diagnostics, Inc., Buffalo NY / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K113020 is the FDA 510(k) clearance record for IMMULISA ENHANCED (TM) CARDIOLIPIN IGA, IGG, IGM AND IGA/IGG/IGM ANTIBODY (ACA) ELISAS, a class II device, cleared for Immco Diagnostics, Inc. on under FDA product code MID (System, Test, Anticardiolipin Immunological). FDA records list 55 510(k) clearances for Immco Diagnostics, Inc., from to . As of , FDA records show no recalls naming K113020.

Clearance record

Decision date
Received
(380 days to decision)
Product code
MID System, Test, Anticardiolipin Immunological
Regulation
21 CFR 866.5660
Device class
Class II
Review panel
Immunology
Applicant
Immco Diagnostics, Inc. 60 Pineview Dr., Buffalo NY
510(k) summary
Statement
Third party review
No

Clearances, product code MID

Trailing 12 months

FDA records hold no clearances under product code MID in the trailing twelve months.

FDA records show no clearances under product code MID in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code MID, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260